Sleep Aids (Pharmacies) - Eastern Asia

  • Eastern Asia
  • Revenue in the Sleep Aids market is projected to reach US$0.76bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 3.14%, resulting in a market volume of US$0.86bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.46 are generated in 2024.

Key regions: South Korea, Japan, Canada, France, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Eastern Asia is experiencing significant growth and development. Customer preferences in the Sleep Aids market in Eastern Asia are driven by several factors. Firstly, there is a growing awareness and concern about sleep disorders and their impact on overall health and well-being. As people become more aware of the importance of a good night's sleep, they are increasingly seeking out sleep aids to help them achieve better sleep quality. Additionally, the fast-paced and high-stress lifestyles in many Eastern Asian countries contribute to sleep problems, leading to a higher demand for sleep aids. Trends in the Sleep Aids market in Eastern Asia include the growing popularity of natural and herbal sleep aids. Consumers in this region are increasingly seeking out products that are perceived as more natural and less likely to have side effects. As a result, there has been a rise in the demand for sleep aids made from herbal ingredients such as valerian root, chamomile, and lavender. Another trend in the market is the increasing availability and use of sleep aids that are specifically tailored to address common sleep problems in Eastern Asian countries. For example, products that target sleep disturbances caused by stress or anxiety are in high demand. Local special circumstances in the Sleep Aids market in Eastern Asia also contribute to its development. One key factor is the aging population in many countries in this region. As the population ages, the prevalence of sleep disorders such as insomnia increases, driving the demand for sleep aids. Additionally, cultural factors play a role in shaping customer preferences in this market. Eastern Asian cultures often prioritize a strong work ethic and long working hours, which can lead to sleep deprivation. This cultural emphasis on productivity and achievement may contribute to the higher demand for sleep aids in this region. Underlying macroeconomic factors further contribute to the development of the Sleep Aids market in Eastern Asia. Economic growth and rising disposable incomes in countries such as China, Japan, and South Korea have led to an increase in consumer spending on health and wellness products, including sleep aids. Additionally, the expanding middle class in these countries has created a larger consumer base for sleep aid products. The increasing urbanization and changing lifestyles in Eastern Asia also contribute to the growth of the Sleep Aids market, as urban dwellers are more likely to experience sleep problems due to factors such as noise pollution and high stress levels. In conclusion, the Sleep Aids (Pharmacies) market in Eastern Asia is experiencing significant growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As awareness about the importance of sleep and the prevalence of sleep disorders continues to increase, the demand for sleep aids is expected to further rise in this region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)